12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Deals

Angioblast Systems, Mesoblast deal

Mesoblast completed its previously announced acquisition of the 67% of partner Angioblast it does not already own. Angioblast shareholders received 90.8 million Mesoblast shares, which...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >